Our dedication to your procedures, providing a full breadth of contrast media products GE Healthcare has a distinguished heritage in contrast media development. Our broad portfolio stems across X-ray/CT, MRI, and Ultrasound modalities . Our products are used in more than 100 million procedures globally every year. That's equivalent to three patients being injected every second.
Appropriate use of contrast media for necessary diagnostic imaging in high risk patients should be considered in order to mitigate the risk of adverse events that these patients are in.1 Visipaque is a third-generation agent with a unique molecular structure developed to further improve the toxicity profile of iodinated contrast agents.2 It is isosmolar to blood with the aim of counteracting major fluid shifts across membranes and limiting discomfort.A9It is also formulated with balanced electrolytes to help minimize effects on cardiac contractile force/fbrillatory propensity.2,3